MGO One Seven’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.01M Sell
9,466
-224
-2% -$44K 0.03% 491
2026
Q1
$1.9M Buy
9,690
+524
+6% +$102K 0.04% 470
2025
Q4
$1.59M Buy
9,166
+233
+3% +$42.4K 0.03% 496
2025
Q3
$1.7M Buy
8,933
+1,890
+27% +$335K 0.04% 441
2025
Q2
$1.27M Buy
7,043
+783
+13% +$136K 0.04% 449
2025
Q1
$1.06M Buy
6,260
+3,467
+124% +$570K 0.04% 432
2024
Q4
$421K Buy
+2,793
New +$434K 0.02% 695
2023
Q2
Sell
-1,674
Closed -$237K 818
2023
Q1
$237K Buy
+1,674
New +$239K 0.02% 748
2021
Q3
Sell
-7,001
Closed -$924K 608
2021
Q2
$924K Sell
7,001
-939
-12% -$123K 0.13% 196
2021
Q1
$1.02M Sell
7,940
-492
-6% -$60.6K 0.18% 146
2020
Q4
$1M Sell
8,432
-64
-0.8% -$7.8K 0.21% 125
2020
Q3
$973K Sell
8,496
-291
-3% -$34.4K 0.23% 107
2020
Q2
$1M Buy
8,787
+128
+1% +$13.6K 0.26% 102
2020
Q1
$695K Buy
+8,659
New +$896K 0.24% 113
2019
Q1
Sell
-268
Closed -$22K 689
2018
Q4
$22K Buy
+268
New +$25.1K 0.01% 884
2018
Q1
$27K Hold
268
0.01% 778
2017
Q4
$26K Buy
+268
New +$25.4K 0.01% 790

Other funds holding DGX

MGO One Seven's DGX Position: Q2 2026 in Review

MGO One Seven reduced its Quest Diagnostics (DGX) stake by 2.3% in Q2 2026, selling an estimated $44K and leaving 9,466 shares worth $2.01M. The position accounts for 0.03% of the portfolio, ranked #491.

MGO One Seven first reported a position in DGX in Q4 2017 and has held it in 17 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • MGO One Seven held 9,466 shares of Quest Diagnostics worth $2.01M as of Q2 2026.
  • MGO One Seven sold 224 Quest Diagnostics shares in Q2 2026, an estimated $44K.
  • Quest Diagnostics made up 0.03% of MGO One Seven's portfolio in Q2 2026, its #491 holding.
  • MGO One Seven first reported a position in Quest Diagnostics in Q4 2017 and has held it in 17 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.